Recent advances phencyclidine model schizophrenia OBJECTIVE Phencyclidine PCP angel dust psychotomimetic state schizophrenia amphetamine-induced psychosis PCP-induced psychosis positive hallucinations paranoia negative emotional withdrawal motor retardation schizophrenic symptoms PCP-induced psychosis formal thought disorder neuropsychological deficits schizophrenia purpose present paper recent advances study molecular mechanisms PCP action implications understanding schizophrenic pathophysiology METHOD Twenty-five papers clinical dose serum CSF levels PCP psychotomimetic effects dose range PCP-induced effects dose range PCP specific molecular targets affects neurotransmission RESULTS PCP-induced psychotomimetic effects submicromolar serum concentrations PCP concentrations PCP specific binding site PCP receptor N-methyl-D-aspartate NMDA excitatory amino acid receptor Occupation receptor PCP induces noncompetitive inhibition NMDA receptor-mediated neurotransmission Other NMDA antagonists dissociative anesthetic ketamine PCP-like neurobehavioral effects proportion potency PCP receptor NMDA receptor inhibition CONCLUSIONS findings endogenous dysfunction NMDA receptor-mediated neurotransmission pathogenesis schizophrenia relative implications PCP amphetamine models schizophrenia relationship diagnosis etiology schizophrenia 